期刊文献+

大鼠骨髓间充质干细胞培养的首次换液模式 被引量:3

Modalities of the first medium exchange during the culture of rat bone-marrow derived mesenchymal stem cells
下载PDF
导出
摘要 背景:细胞的培养时间、数量及纯度是影响干细胞移植的关键因素,优化体外细胞培养模式可以提高移植的成效。目的:观察不同的首次换液模式、相同的后期换液条件对大鼠骨髓间充质干细胞培养时间及生物学特性的影响。方法:全骨髓贴壁法培养SD大鼠骨髓间充质干细胞,按首次换液方式分为以下6组:24h半量换液组、24h全量换液组48h半量换液组、48h全量换液组、72h半量换液组、72h全量换液组,以后每4h全量换液。记录各组第0~3代培养时间及细胞纯度。结果与结论:各组培养总时间比较差异有显著性意义(F=46.455,P<0.05),48h全量换液组最短,24h全量换液组最长与其他组比较差异均有显著性意义(P<0.05)。24h全量换液组各代细胞纯度均最高,72h半量换液组各代细胞纯度均最低与其他组比较差异均有显著性意义(P<0.05)。所获细胞CD29、CD90阳性,CD34、CD45阴性,可以向成骨、成脂诱导分化。结果显示首次换液方式能影响大鼠骨髓间充质干细胞的培养周期及其纯度,48h半量换液为最佳首次换液方式。 BACKGROUND: The culture period, quantity and purity are crucial for stem cell transplantation, and it is essential to build an optimal modality of cell culture in vitro. OBJECTIVE: To study the influence of different modalities of the first medium exchange on the culture time and biological characteristics of rat bone marrow-derived mesenchymal stem cells. METHODS: On condition of modality of the first medium exchange, six experimental groups were performed as follows: group A was half exchanged after 24 hours, group B was all exchanged after 24 hours, group C was half exchanged after 48 hours, group D was all exchanged after 48 hours, group E was half exchanged after 72 hours, group F was all exchanged after 72 hours. Then, all groups were all exchanged every 48 hours and were subcultured consecutively. The period and purity of each passage were measured. RESULTS AND CONCLUSION: The total culture time was significant different (F=46.455, P 0.001). Group D was the least while group B was the longest, and both of the two groups were significant different compared with others (P 0.05). Group B earned the highest purity in all passages and group E the lowest, and both of the two groups were significant different compared with others (P 0.05). Cells of passage 4 showed CD29, CD90 positive, induced to differentiate into osteoblasts and adipocytes. The modality of the first medium exchange had an influence on the culture period and purity of bone marrow-derived mesenchymal stem cells, and the modality of 48-hour half exchange was the best protocol.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第32期5891-5895,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 福建省社会发展计划重点项目(2009Y0037) 福建省自然科学基金(2009J001187) 南京军区医学科技创新重点课题(09Z029)~~
  • 相关文献

参考文献16

  • 1Bi Y,Gong M,Zhang X,et al.Pre-activation of retinoid signaling facilitates neuronal differentiation of mesenchymal stem cells.Dev Growth Differ.2010;52(5):419-431.
  • 2Zhang XQ,Li X,Wu T,et al.Isolation,culture and chondrogenic differentiation of goat bone marrow mesenchymal stem cells.Nan Fang Yi Ke Da Xue Xue Bao.2009;29(3):419-422.
  • 3Shi ZB,Wang KZ.Effects of recombinant adeno-associated viral vectors on angiopoiesis and osteogenesis in cultured rabbit bone marrow stem cells via co-expressing hVEGF and hBMP genes:a preliminary study in vitro.Tissue Cell.2010;42(5):314-321.
  • 4Sotiropoulou PA,Perez SA,Salagianni M,et al.Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.Stem Cells.2006;24(2):462-471.
  • 5Li Y,Chopp M.Marrow stromal cell transplantation in stroke and traumatic brain injury.Neurosci Lett.2009;456(3):120-123.
  • 6Saulnier N,Lattanzi W,Puglisi MA,et al.Mesenchymal stromal cells multipotency and plasticity:induction toward the hepatic lineage.Eur Rev Med Pharmacol Sci.2009;13 Suppl 1:71-78.
  • 7Eibes G,dos Santos F,Andrade PZ,et al.Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system.J Biotechnol.2010; 146(4):194-197.
  • 8Ding DC,Shyu WC,Lin SZ.Mesenchymal stem cells.Cell Transplant.2011;20(1):5-14.
  • 9黎婷,孙晋虎,赵亮,李帅.离心分离法与贴壁分离法对培养骨髓间充质干细胞生物学特性影响[J].中国现代医生,2010,48(5):29-31. 被引量:8
  • 10Hou J,Li Y,Zhou Z,et al.Antiproliferative property of hexadecyloxypropyl 9-[2-(phosphonomethoxy) ethyl] guanine (HDP-PMEG) for unwanted ocular proliferation.Mol Vis.2011;17:627-637.

二级参考文献21

  • 1石娇,于维军,祝素文,孙桂媛.器官型脑片培养液对BMSCs向神经元样细胞分化的诱导作用[J].中国组织化学与细胞化学杂志,2006,15(3):338-341. 被引量:3
  • 2Stagg J, Pommey S, Eliopoulos N, et al. Interferon - γ - stimulated marrow stromal cells: a new type of nonhematopoietic antigen - presenting cell [ J ]. Blood ,2006,107 (6) :2570 - 2577.
  • 3Smits AM, van Vliet P, Hassink R J, et al. The role of stem cells in cardiac regeneration [J]. J Cell Mol Med, 2005, 9(1) :25 -36.
  • 4Docheva D, Popov C, Mutschler W, et al. Human mesenchymal stem ceils in contact with their environment: surface characteristics and the integrin system [J]. J Cell Mol Med,2007,11 (1) :21 - 38.
  • 5Friedenstein AJ. Precursor cells of mechanocytes [ J ]. Int Rev Cytol, 1976, 47:327-359.
  • 6Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues [ J ]. Science, 1997, 276 (5309) :71 - 74.
  • 7Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells [J]. Science, 1999, 284 (5411) :143 - 147.
  • 8Hong L, Peptan I, Clark P, et al. Ex vivo adipose tissue engineering by human marrow stromal cell seeded gelatin sponge [ J ]. Ann Biomed Eng, 2005, 33(4) : 511 -517.
  • 9Colter DC, Class R, DiGirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic - adherent cells from human bone marrow [J]. Proc Natl Acad Sei USA, 2000, 97(7) :3213 - 3218.
  • 10Tropel P, Noel D, Platet N, et al. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow [ J ]. Exp Cell Res, 2004,295(2) :395 -406.

共引文献12

同被引文献14

  • 1Stevens Molly M. Biomater ials for bone tissue eng ineer ing[J]. Mater Today, 2008, 11(5) :18.
  • 2Bran Greg or M, SterrStraeter Jens, Hrmann Karl, et al. Aim pt osis in bone for tissue engineer ing [ J ]. Ar ch Meal Res,2008,39 ( 5 ) :468.
  • 3Pittenger MF, MackayAM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cell [ J ]. Science,1999,284(5411 ) :143 - 147.
  • 4夏远军,沈霖,李蕾.骨伤科实验研究[M].北京:科学技术出版社,2005:214-216.
  • 5DanielR.Marshar.干细胞生物学[M].北京:化学工业出版社.2005:302-323.
  • 6Lasala GP, Minguell JJ. Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocar dial infarction [J]. Heart Lung Circ, 2009, 18(3):171-180.
  • 7Shahdadfar A, Fronsdal K, Haug T, et al. In vitro expansion of human mesenchymal stem cells: choice of serum is a deter minant of cell proliferation, differentiation, gene expression, and transeriptome stability[J].Stem Cells, 2005, 23(9): 1357-1366.
  • 8Psaltis PJ, Zannettino AC, Worthley SG, et al. Concise re- view:mesenchymal stromal cells.-potential for cardiovascular repair.[J]. Stem Cells, 2008, 26(9):2201-2210.
  • 9Kane NM, Xiao QZ, Andrew H, et al. Pluripotent stem cell differentiation into vascular cells: A novel technology with promises for vascular re(generation) [J].Pharmacol Ther, 2011 Jan; 129(1) ,29-49.
  • 10Turnovcova K, Ruzickova K, Vanecek V, et al. Properties and growth of human bone marrow mesenchymal stromal cells cul tivated in different media, [J].Cytotherapy, 2009, 11, (7) 874-885.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部